相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits
Lieske H. Schrijver et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)
Menopausal Hormone Therapy Formulation and Breast Cancer Risk
Haim A. Abenhaim et al.
OBSTETRICS AND GYNECOLOGY (2022)
The 2022 hormone therapy position statement of The North American Menopause Society
Stephanie S. Faubion et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2022)
Beyond the pill: contraception and the prevention of hereditary ovarian cancer
Yue Yin Xia et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2022)
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
Lieske H. Schrijver et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium
Anna Morra et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Trends in oral contraceptive and intrauterine device use among reproductive-aged women in the US from 1999 to 2017
Lauren A. King et al.
CANCER CAUSES & CONTROL (2021)
Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery
Chrisandra L. Shufelt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study
Marthe M. de Jonge et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 12 months after premenopausal risk-reducing salpingo-oophorectomy
Martha Hickey et al.
GYNECOLOGIC ONCOLOGY (2021)
Levonorgestrel-releasing intrauterine system and breast cancer risk: A systematic review and meta-analysis
Livia Conz et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2020)
Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement This practice statement has been endorsed by The North American Menopause Society
A. K. Sinno et al.
GYNECOLOGIC ONCOLOGY (2020)
Clinical Effects of Early or Surgical Menopause
Sheryl A. Kingsberg et al.
OBSTETRICS AND GYNECOLOGY (2020)
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials
Rowan T. Chlebowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
BRCA-Related Cancer Genetic Counseling is Indicated in Many Women Seeking Primary Care
Daniel J. Parente
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2020)
Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits
Sushmita Gordhandas et al.
GYNECOLOGIC ONCOLOGY (2019)
Reproductive and Hormonal Considerations in Women at Increased Risk for Hereditary Gynecologic Cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review
Lee-may Chen et al.
GYNECOLOGIC ONCOLOGY (2019)
Is Hormone Replacement Therapy Safe in Women With a BRCA Mutation?: A Systematic Review of the Contemporary Literature
Nicole Birrer et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History
Giovanni Grandi et al.
CLINICAL BREAST CANCER (2018)
Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014
Megan L. Kavanaugh et al.
CONTRACEPTION (2018)
Migraine Throughout the Female Reproductive Life Cycle
Stephanie S. Faubion et al.
MAYO CLINIC PROCEEDINGS (2018)
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers
Joanne Kotsopoulos et al.
JAMA ONCOLOGY (2018)
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis
C. Marchetti et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Hereditary Cancer Risk Assessment and Genetic Testing in the Community-Practice Setting
Mark S. DeFrancesco et al.
OBSTETRICS AND GYNECOLOGY (2018)
Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study
Lieske H. Schrijver et al.
JNCI CANCER SPECTRUM (2018)
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality The Women's Health Initiative Randomized Trials
Joann E. Manson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Contemporary Hormonal Contraception and the Risk of Breast Cancer
Lina S. Morch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones
Yiwey Shieh et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Exogenous Hormone Use: Oral Contraceptives, Postmenopausal Hormone Therapy, and Health Outcomes in the Nurses' Health Study
Shilpa N. Bhupathiraju et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2016)
Youth Risk Behavior Surveillance - United States, 2015
Laura Kann et al.
MMWR SURVEILLANCE SUMMARIES (2016)
US Medical Eligibility Criteria for Contraceptive Use, 2016
Kathryn M. Curtis et al.
MMWR RECOMMENDATIONS AND REPORTS (2016)
Hormone Therapy and Young-Onset Breast Cancer
Katie M. O'Brien et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2015)
Long-term health consequences of premature or early menopause and considerations for management
S. S. Faubion et al.
CLIMACTERIC (2015)
Risk management options elected by women after testing positive for a BRCA mutation
Christine Garcia et al.
GYNECOLOGIC ONCOLOGY (2014)
The Mortality Toll of Estrogen Avoidance: An Analysis of Excess Deaths Among Hysterectomized Women Aged 50 to 59 Years
Philip M. Sarrel et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2013)
Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials
JoAnn E. Manson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Oral Contraceptives and Risk of Ovarian Cancer and Breast Cancer Among High-Risk Women: A Systematic Review and Meta-Analysis
Patricia G. Moorman et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Long-Term Mortality Associated With Oophorectomy Compared With Ovarian Conservation in the Nurses' Health Study
William H. Parker et al.
OBSTETRICS AND GYNECOLOGY (2013)
Premature menopause or early menopause and risk of ischemic stroke
Walter A. Rocca et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2012)
Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer
Juergen Dinger et al.
CONTRACEPTION (2011)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
Eva Gonzalez-Suarez et al.
NATURE (2010)
Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
Timothy R. Rebbeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses' Health Study
William H. Parker et al.
OBSTETRICS AND GYNECOLOGY (2009)
Effect of Reproductive Factors and Oral Contraceptives on Breast Cancer Risk in BRCA1/2 Mutation Carriers and Noncarriers: Results from a Population-Based Study
Eunjung Lee et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women
Rulla M. Tamimi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study
John R. McLaughlin et al.
LANCET ONCOLOGY (2007)
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study
Walter A. Rocca et al.
LANCET ONCOLOGY (2006)
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50
Robert W. Haile et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers:: The PROSE Study Group
TR Rebbeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Use of the levonorgestrel-releasing intrauterine system and breast cancer
T Backman et al.
OBSTETRICS AND GYNECOLOGY (2005)
Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations
RL Milne et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Breast cancer and hormone-replacement therapy in the Million Women Study
E Banks et al.
LANCET (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer
DM Gabrick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)